Cargando…
Expanding the utility of the dextran sulfate sodium (DSS) mouse model to induce a clinically relevant loss of intestinal barrier function
BACKGROUND: Inflammatory bowel disease (IBD) is a family of debilitating disorders that affects more than 1 million people in the United States. Many animal studies of IBD use a dextran sulfate sodium (DSS) mouse model of colitis that induces rapid and severe colitis symptoms. Although the typical s...
Autores principales: | Cochran, Kyle E., Lamson, Nicholas G., Whitehead, Kathryn A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069414/ https://www.ncbi.nlm.nih.gov/pubmed/32195049 http://dx.doi.org/10.7717/peerj.8681 |
Ejemplares similares
-
Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
por: Whittem, Caitlyn G., et al.
Publicado: (2010) -
Orally delivered β-glucans aggravate dextran sulfate sodium (DSS)-induced intestinal inflammation
por: Heinsbroek, Sigrid E.M., et al.
Publicado: (2015) -
Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis
por: Chao, Liu, et al.
Publicado: (2017) -
Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice
por: Jeengar, Manish Kumar, et al.
Publicado: (2017) -
Blackcurrant Alleviates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice
por: Moon, Hye-Jung, et al.
Publicado: (2023)